Synthesis and biological evaluation of novel photo-clickable adenosine and cyclic ADP-ribose analogs: 8-N-2'-O-propargyladenosine and 8-N-2'-O-propargyl-cADPR.

Bioorg Med Chem

Department of Medicinal and Biological Chemistry, College of Pharmacy and Pharmaceutical Sciences, University of Toledo, 3000 Arlington Avenue, Toledo, OH 43614, USA. Electronic address:

Published: December 2022

A photo-clickable analog of adenosine was devised and synthesized in which the photoactive functional group (8-azidoadenosine) and the click moiety (2'-O-propargyl-ether) were compactly combined within the structure of the adenosine nucleoside itself. We synthesized 8-N-2'-O-propargyl adenosine in four steps starting from adenosine. This photo-clickable adenosine was 5'-phosphorylated and coupled to nicotinamide mononucleotide to form the NAD analog 8-N-2'-O-propargyl-NAD. This NAD analog was recognized by Aplysia californica ADP-ribosyl cyclase and enzymatically cyclized producing 8-N-2'-O-propargyl cyclic ADP-ribose. Photo-clickable cyclic-ADP-ribose analog was envisioned as a probe to label cyclic ADP-ribose binding proteins. The monofunctional 8-N-cADPR has previously been shown to be an antagonist of cADPR-induced calcium release [T.F. Walseth et. al., J. Biol. Chem (1993) 268, 26686-26691]. 2'-O-propargyl-cADPR was recognized as an agonist which elicited Ca release when added at low concentration to sea urchin egg homogenates. The bifunctional 8-N-2'-O-propargyl cyclic ADP-ribose did not elicit Ca release at low concentration or impact cyclic ADP-ribose mediated Ca release either when added to sea urchin egg homogenates or when microinjected into cultured human U2OS cells. The photo-clickable adenosine will none-the-less be a useful scaffold for synthesizing photo-clickable probes for identifying proteins that interact with a variety of adenosine nucleotides.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842072PMC
http://dx.doi.org/10.1016/j.bmc.2022.117099DOI Listing

Publication Analysis

Top Keywords

cyclic adp-ribose
20
photo-clickable adenosine
12
adenosine
8
nad analog
8
8-n-2'-o-propargyl cyclic
8
release low
8
low concentration
8
sea urchin
8
urchin egg
8
egg homogenates
8

Similar Publications

Gap junction intercellular communications regulates activation of SARM1 and protects against axonal degeneration.

Cell Death Dis

January 2025

State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical Genomics, Peking University Shenzhen Graduate School, Shenzhen, 518055, China.

Sterile alpha and Toll/interleukin-1 receptor motif containing 1 (SARM1), a nicotinamide adenine dinucleotide (NAD)-utilizing enzyme, mediates axon degeneration (AxD) in various neurodegenerative diseases. It is activated by nicotinamide mononucleotide (NMN) to produce a calcium messenger, cyclic ADP-ribose (cADPR). This activity is blocked by elevated NAD level.

View Article and Find Full Text PDF

Colorectal cancer (CRC) ranks third globally in cancer incidence and mortality, posing a significant human concern. Recent advancements in immunotherapy are noteworthy. This study explores immune modulation for CRC treatment.

View Article and Find Full Text PDF

Single phage proteins sequester signals from TIR and cGAS-like enzymes.

Nature

November 2024

State Key Laboratory of Chemical Resource Engineering, Beijing Advanced Innovation Center for Soft Matter Science and Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.

Prokaryotic anti-phage immune systems use TIR and cGAS-like enzymes to produce 1''-3'-glycocyclic ADP-ribose (1''-3'-gcADPR) and cyclic dinucleotide (CDN) and cyclic trinucleotide (CTN) signalling molecules, respectively, which limit phage replication. However, how phages neutralize these distinct and common systems is largely unclear. Here we show that the Thoeris anti-defence proteins Tad1 and Tad2 both achieve anti-cyclic-oligonucleotide-based anti-phage signalling system (anti-CBASS) activity by simultaneously sequestering CBASS cyclic oligonucleotides.

View Article and Find Full Text PDF

Emergence of cyclic hypoxia and the impact of PARP inhibitors on tumor progression.

NPJ Syst Biol Appl

October 2024

Departamento de Matemática Aplicada and Research Unit "Modeling Nature" (MNat), Universidad de Granada, Avenida de la Fuente Nueva S/N, Granada, 18071, Spain.

Article Synopsis
  • Tumor hypoxia involves fluctuating oxygen levels that occur over short (seconds to minutes) and long (hours to days) periods, with the longer cycles not being fully understood.
  • The study introduces a mathematical model explaining these long cycles through mechanisms like vascular changes, tumor growth influenced by oxygen, and the production of toxic cytokines, while highlighting the importance of endothelial cell receptor adaptation.
  • Additionally, the research suggests that using PARP inhibitors may help manage hypoxia by targeting tumor cell proliferation, pointing to new therapeutic strategies involving PARP proteins.
View Article and Find Full Text PDF

Replication Stress Is an Actionable Genetic Vulnerability in Desmoplastic Small Round Cell Tumors.

Cancer Res

January 2025

The ATIP-Avenir Inserm and ERC StG (Epi)genetic Vulnerabilities in Solid Tumors and Sarcoma Laboratory, Inserm Unit UMR 981, Université Paris-Saclay, Gustave Roussy, Villejuif, France.

Article Synopsis
  • Desmoplastic small round cell tumor (DSRCT) is an aggressive form of cancer linked to a specific genetic factor called EWS-WT1, and treatment options have not improved significantly in over 20 years.
  • Researchers conducted a comprehensive drug sensitivity test on DSRCT cells and found that they respond well to PARP and ATR inhibitors, both alone and in combination, showcasing these treatments across various models.
  • The study reveals that the combination of these inhibitors causes significant DNA damage and activates immune responses, suggesting that targeting EWS-WT1 could be an effective strategy in treating DSRCT.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!